Closed-loop opportunity Tandem is actively advancing fully automated insulin delivery systems and is collaborating with other industry players on seamless integration to remove meal announcements from diabetes management. This creates a sales opportunity to position compatible hardware and related services with hospitals, clinics, and payer networks seeking streamlined insulin delivery workflows.

International expansion Recent news highlights compatibility launches of the t:slim X2 in multiple international markets and ongoing expansions. This suggests a channel strategy ripe for regional distributors, training programs, and localized support services to accelerate adoption and patient reach in new geographies.

Data integration Glooko cloud integration and the push for automatic pump data access indicates demand for interoperable data ecosystems. There is a clear sales angle for expanded telemetry, remote patient monitoring partnerships, and bundled data analytics solutions for care teams.

Provider education Tandem is investing in healthcare provider education on pregnancy and type 1 diabetes at major conferences. This creates opportunities to offer targeted educational programs, clinical resources, and integrated care pathways to obstetrics, pediatric, and endocrinology practices.

Competitive positioning With competition intensifying from Abbott, Medtronic, Insulet, and others in closed-loop and sensor ecosystems, there is a need for differentiated value props such as ease of use, safety features, and bundled support. A sales approach can emphasize Tandem’s Control-IQ technology, customer loyalty, and strong patient advocacy feedback to win equitable partnerships and hospital contracts.